Third Covid vaccine dose available only in pvt hospitals. Health officials say routine procedures need to be brought back on track, but govt hospitals could be brought in if needed.
CEO of world’s largest vaccine maker says India is better equipped to deal with pandemics now, adds a global treaty is important to allow resource-sharing across borders.
Bharat Biotech is believed to have assured Government of India that it will ‘quickly’ reply to WHO about ‘deficiencies found in its manufacturing’ during an inspection last month.
The Indian vaccine maker has committed to address deficiencies in good manufacturing practices and is developing an action plan, WHO said, without specifying when the suspension will be lifted.
Govt was responding to question on availability of safety & efficacy data for Corbevax, and whether it had been peer-reviewed. It sidestepped queries on efficacy & peer-review.
Hyderabad-based Biological E has priced its vaccine at Rs 990 in the private market. For the government, however, the vaccine is at just Rs 145, making it very affordable.
Daily Covid-19 cases have been recorded at less than one lakh for the last 11 consecutive days, while the recovery rate crossed 98% for the first time since 5 January.
By Monday, 1,73,29,125 precaution doses had been administered, including to over 80 lakh senior citizens. Govt has made multiple public appeals to take precaution dose.
The study published by the US Centers for Disease Control and Prevention also found that fewer hospitalised patients died due to Omicron compared to when Delta variant was dominant.
Economists say there are weaknesses in India’s GDP data. But statisticians claim the accusations are based on flawed understanding, saying while GDP has problems, the economists are looking in the wrong places.
COMMENTS